The Current Ratio as of December 2025 (TTM) for Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) is 1.52

According to Chengdu Olymvax Biopharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.52. This represents a change of -2.72% compared to the average of 1.57 of the last 4 quarters.

Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) Historical Current Ratio (quarterly & annually)

How has 688319.SS Current Ratio performed in the past?

The mean historical Current Ratio of Chengdu Olymvax Biopharmaceuticals Inc. over the last ten years is 1.51. The current 1.52 Current Ratio has changed 9.98% with respect to the historical average. Over the past ten years (40 quarters), 688319.SS's Current Ratio was at its highest in in the March 2018 quarter at 3.37. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Chengdu Olymvax Biopharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) Average Current Ratio

How has 688319.SS Current Ratio performed in the past?

The current Current Ratio of Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) Current Ratio vs. Peers

How is 688319.SS’s Current Ratio compared to its peers?

Chengdu Olymvax Biopharmaceuticals Inc.’s Current Ratio is greater than Chengzhi Shareholding Co., Ltd. (1.46), less than Chengdu Kanghua Biological Products Co., Ltd. (5.85), less than Aurisco Pharmaceutical Co.,Ltd. (4.30), less than Youcare Pharmaceutical Group Co., Ltd. (1.84), less than Daan Gene Co., Ltd. (3.06), greater than Anhui Huaheng Biotechnology Co., Ltd. (1.44), less than Chengdu Easton Biopharmaceuticals Co., Ltd. (3.50), less than Nanjing Vazyme Biotech Co., Ltd. (3.73), less than Guilin Sanjin Pharmaceutical Co., Ltd. (3.13), less than Zhejiang Ausun Pharmaceutical Co., Ltd. (2.84),

Build a custom stock screener for Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chengdu Olymvax Biopharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chengdu Olymvax Biopharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.